关注
Robert Montal
Robert Montal
Cancer Biomarkers Research Group (GReBiC) – IRB Lleida.
在 gencat.cat 的电子邮件经过验证
标题
引用次数
引用次数
年份
Molecular therapies and precision medicine for hepatocellular carcinoma
JM Llovet, R Montal, D Sia, RS Finn
Nature reviews Clinical oncology 15 (10), 599-616, 2018
16322018
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
R Pinyol, R Montal, L Bassaganyas, D Sia, T Takayama, GY Chau, ...
Gut 68 (6), 1065-1075, 2019
2442019
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
R Montal, D Sia, C Montironi, WQ Leow, R Esteban-Fabró, R Pinyol, ...
Journal of hepatology 73 (2), 315-327, 2020
2192020
Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC
R Lencioni, R Montal, F Torres, JW Park, T Decaens, JL Raoul, M Kudo, ...
Journal of hepatology 66 (6), 1166-1172, 2017
2172017
Randomized trials and endpoints in advanced HCC: role of PFS as a surrogate of survival
JM Llovet, R Montal, A Villanueva
Journal of hepatology 70 (6), 1262-1277, 2019
1892019
Evidence-based management of hepatocellular carcinoma: systematic review and meta-analysis of randomized controlled trials (2002–2020)
PK Haber, M Puigvehí, F Castet, V Lourdusamy, R Montal, P Tabrizian, ...
Gastroenterology 161 (3), 879-898, 2021
1672021
Mixed hepatocellular cholangiocarcinoma tumors: cholangiolocellular carcinoma is a distinct molecular entity
A Moeini, D Sia, Z Zhang, G Camprecios, A Stueck, H Dong, R Montal, ...
Journal of hepatology 66 (5), 952-961, 2017
1562017
Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials
R Montal, C Andreu-Oller, L Bassaganyas, R Esteban-Fabró, S Moran, ...
British journal of cancer 121 (4), 340-343, 2019
952019
Copy-number alteration burden differentially impacts immune profiles and molecular features of hepatocellular carcinoma
L Bassaganyas, R Pinyol, R Esteban-Fabró, L Torrens, S Torrecilla, ...
Clinical Cancer Research 26 (23), 6350-6361, 2020
462020
Microenvironmental reactive oxygen species in colorectal cancer: involved processes and therapeutic opportunities
MA Sorolla, I Hidalgo, A Sorolla, R Montal, O Pallisé, A Salud, E Parisi
Cancers 13 (20), 5037, 2021
322021
Objective response predicts survival in advanced hepatocellular carcinoma treated with systemic therapies
M Kudo, R Montal, RS Finn, F Castet, K Ueshima, N Nishida, PK Haber, ...
Clinical Cancer Research 28 (16), 3443-3451, 2022
312022
New drugs effective in the systemic treatment of hepatocellular carcinoma
C Montironi, R Montal, JM Llovet
Clinical liver disease 14 (2), 56-61, 2019
262019
Epigenetic inactivation of the 5-methylcytosine RNA methyltransferase NSUN7 is associated with clinical outcome and therapeutic vulnerability in liver cancer
V Ortiz-Barahona, M Soler, V Davalos, CA García-Prieto, M Janin, ...
Molecular Cancer 22 (1), 83, 2023
182023
Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies
D Azuara, C Santos, A Lopez-Doriga, J Grasselli, M Nadal, X Sanjuan, ...
Molecular Cancer Therapeutics 15 (5), 1106-1112, 2016
182016
Molecular predictors of recurrence prevention with sorafenib as adjuvant therapy in hepatocellular carcinoma: Biomarker study of the STORM phase III trial
R Pinyol, R Montal, T Takayama, GY Chau, V Mazzaferro, S Roayaie, ...
Journal of Hepatology 66 (1), S12-S13, 2017
132017
Salvage surgery after head and neck squamous cell carcinoma treated with bioradiotherapy
A Rovira, J Tornero, M Oliva, M Taberna, R Montal, J Nogues, A Farre, ...
Head & Neck 39 (1), 116-121, 2017
122017
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy
CJ O'Rourke, M Salati, C Rae, G Carpino, H Leslie, A Pea, MG Prete, ...
Gut 73 (3), 496-508, 2024
92024
Prognostic factors involved in the epithelial–mesenchymal transition process in colorectal cancer have a preponderant role in oxidative stress: A systematic review and meta …
E Parisi, A Sorolla, R Montal, R González-Resina, A Novell, A Salud, ...
Cancers 12 (11), 3330, 2020
62020
Residual neck disease management in squamous-cell carcinoma of the head and neck treated with radiotherapy plus cetuximab
R Montal, M Oliva, M Taberna, L De Avila, A Rovira, M Cos, M Mañós, ...
Clinical and Translational Oncology 18, 1140-1146, 2016
62016
Reply to:“mRECIST for systemic therapies: More evidence is required before recommendations could be made”
R Montal, R Lencioni, JM Llovet
Journal of hepatology 67 (1), 196-197, 2017
52017
系统目前无法执行此操作,请稍后再试。
文章 1–20